222 related articles for article (PubMed ID: 31783700)
21. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract][Full Text] [Related]
22. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
Yan S; Jiang Y; Liang C; Cheng M; Jin C; Duan Q; Xu D; Yang L; Zhang X; Ren B; Jin P
J Cell Biochem; 2018 May; 119(5):4113-4119. PubMed ID: 29240249
[TBL] [Abstract][Full Text] [Related]
23. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
24. Expression of Caudal-Type Homologous Transcription Factor-2 (CDX2) in Duodenal Carcinoma and its Relationship with Prognosis.
Pan J; Jiao X; Yang Z; Li J; Chen Y; Chu X
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518166
[TBL] [Abstract][Full Text] [Related]
25. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
[TBL] [Abstract][Full Text] [Related]
26. Loss of
Caldas ÁMC; Nunes WA; Taboada R; Cesca MG; Germano JN; Riechelmann RP
Ecancermedicalscience; 2024; 18():1666. PubMed ID: 38439814
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
28. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
Yang L; Men WL; Yan KM; Tie J; Nie YZ; Xiao HJ
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4837-4845. PubMed ID: 30070320
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
30. CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.
Pilati C; Taieb J; Balogoun R; Marisa L; de Reyniès A; Laurent-Puig P
Ann Oncol; 2017 May; 28(5):1032-1035. PubMed ID: 28328000
[TBL] [Abstract][Full Text] [Related]
31. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
[TBL] [Abstract][Full Text] [Related]
32. The role of transcription factor caudal-related homeobox transcription factor 2 in colorectal cancer.
Wu CC; Hsu TW; Yeh CC; Huang HB
Tzu Chi Med J; 2020; 32(4):305-311. PubMed ID: 33163374
[TBL] [Abstract][Full Text] [Related]
33. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
34. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer.
Lin M; Duan B; Hu J; Yu H; Sheng H; Gao H; Huang J
Oncol Lett; 2017 Jul; 14(1):1061-1067. PubMed ID: 28693274
[TBL] [Abstract][Full Text] [Related]
36. CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better
Aasebø K; Dragomir A; Sundström M; Mezheyeuski A; Edqvist PH; Eide GE; Ponten F; Pfeiffer P; Glimelius B; Sorbye H
Front Oncol; 2020; 10():8. PubMed ID: 32117703
[No Abstract] [Full Text] [Related]
37. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of serum miR-140-5p predicts poor prognosis of patients with colorectal cancer.
Li J; Gao J; Tian W; Li Y; Zhang J
Int J Clin Exp Pathol; 2017; 10(9):9503-9508. PubMed ID: 31966825
[TBL] [Abstract][Full Text] [Related]
39. Methylation of promoter region of
Wang Y; Li Z; Li W; Liu S; Han B
Oncol Lett; 2016 Nov; 12(5):3229-3233. PubMed ID: 27899987
[TBL] [Abstract][Full Text] [Related]
40. CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p.
Jiang Y; Zhang Y; Li F; Du X; Zhang J
Tumour Biol; 2016 Jan; 37(1):1041-9. PubMed ID: 26269116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
